• The NeuroCircuit
  • Posts
  • Weekly Signal 20 | Inner-Speech BCI, ENCELTO milestone đź§ 

Weekly Signal 20 | Inner-Speech BCI, ENCELTO milestone đź§ 

BCI, industry moves, and neural privacy—this week’s signals.

Table of Contents

đź§  Weekly Signal

Neurotechnology News | August 9 – August 15, 2025

Let's cut through the noise this week!

This week, we saw a peer-reviewed brain–computer interface decode inner speech in paralyzed patients and the first commercial ENCELTO procedure for macular telangiectasia. Meanwhile, neuromodulation financing accelerated and neural data laws gained clarity. Bottom line: core clinical translation is advancing as governance and capital align.

đź§  SCIENCE & CLINICAL TRIALS

🟢 BCI decodes “inner speech” with a user-controlled password\

Published: August 14, 2025
Read more ➡️ Nature News / Cell

Researchers implanted microelectrode arrays and used AI to decode imagined speech in people with severe paralysis, adding a “think-to-unlock” passphrase to prevent unintended decoding. Results show near–real-time decoding of internal chatter and introduce a concrete privacy control.

💡 Big Picture: Thought-to-text BCIs are moving beyond attempted speech toward true inner speech — forcing privacy-by-design into neurotech.

🟢 First FDA-approved MacTel therapy (ENCELTO) performed and shipped

Published: August 11–12, 2025
Read more ➡️ Modern Retina / Neurotech Pharmaceuticals press release

Neurotech began commercial manufacturing, shipment, and the first surgical procedure of ENCELTO (encapsulated cell-based gene therapy) for idiopathic Macular Telangiectasia Type 2. This marks the clinical rollout of the first FDA-approved therapy for MacTel.

💡 Big Picture: Beyond approval, real-world deployment has started — the milestone that actually changes patient access.

đź’Ľ INDUSTRY & STARTUPS

🟢 SetPoint Medical raises $140M to commercialize neuroimmune modulation for RA

Published: August 11, 2025
Read more ➡️ Yahoo Finance / Company statement — SetPoint press release

Fresh financing (Series C tranche + Series D) follows FDA approval of SetPoint’s implant that stimulates the vagus nerve to modulate inflammation in rheumatoid arthritis. Proceeds target U.S. launch and pipeline expansion in other autoimmune diseases.

💡 Big Picture: Bioelectronic medicine is scaling from trials to commercialization — with major strategics watching the space.

🏛️ POLICY & ETHICS

🟢 States sharpen definitions of “neural data” in privacy laws

Published: August 12, 2025
Read more ➡️ Future of Privacy Forum memo

FPF details how four U.S. states now explicitly regulate “neural/neurotechnology data,” highlighting divergent definitions and protections emerging across statutes. Coverage this week underscores growing legislative focus on mental-privacy as BCIs evolve.

đź’ˇ Big Picture: Expect a patchwork: compliance for neurotech products will hinge on jurisdiction-specific definitions of neural data.

⚡ Weekly Signal Summary Table

Signal

Insight

Future Impact

Inner-speech BCI

Real-time decoding + “think-to-unlock”

Privacy-by-design becomes a BCI requirement.

MacTel therapy performed

ENCELTO moves from approval to first surgeries

Broader retinal gene-therapy care pathways.

SetPoint $140M

Capital to launch RA neurostimulation

Bioelectronic medicine enters mainstream clinics.

Neural data laws

States define “neural data” differently

Fragmented compliance; need for harmonization.

🎯 Community Challenge

Ready to take neurotech to the next level? Share your insights, projects, ideas, our upcoming list of NeuroHacks, or your own groundbreaking work—and watch the inspiration ripple across the community!

How to Participate

  1. Follow HackTheNeuron

    Show us support by following us on X, Instagram and Tik Tok!

  2. Create a Post
    Show us what you’re working on—DIY projects, research breakthroughs, or even your latest neurotech musings.

  3. Use #Neurotech
    This helps your ideas reach fellow enthusiasts and potential collaborators.

  4. Mention @HackTheNeuron
    Tag us directly in your post so we never miss your entry—and we’ll amplify your work across our entire NeuroCircuit community!

Why Join?

  • Boost Your Reach: Tap into a niche but fast-growing community for extra visibility.

  • Build Your Network: Connect with researchers, developers, and curious tinkerers who share your passion.

  • Shape Neurotech’s Future: Your project or insight could spark the next big breakthrough—or inspire someone else’s.

We can’t wait to see your creativity in action! Fire up X, LinkedIn, Facebook, Instagram, or TikTok, and spread the word. Let’s spark innovation together!

🚀Recruit More Neurohackers

Your referrals are the engine that drives our community forward. Share your unique referral link with friends, colleagues, or fellow neurotech enthusiasts—and watch us grow together!

  • Spread the Word: Copy your personal referral link and post it on social, forums, or in emails.

  • Unlock Exclusive Perks: Every friend who subscribes through your link brings you closer to special rewards—insider insights, private Discord access, early project previews, and more.

  • Be the Catalyst: The more you share, the stronger our network becomes. Help us build the ultimate neurotech hub—one referral at a time!

✍️Help Us Improve

Your input is what will make The NeuroCircuit and Hack The Neuron better. Let us know what you’d like more of—and what we can do differently.

  • Share Your Ideas: Tell us which topics, features, or formats you’d love to see next.

  • Spot the Gaps: Let us know if anything’s missing or unclear in our content and community tools.

  • Shape the Experience: Whether it’s new challenges, tutorials, or platform features, your suggestions guide our roadmap.

Reply

or to participate.